Administering GnRH Agonists in the luteal phase of Artificial Cycle Frozen-Thawed Embryo Transfers. A prospective randomized study;Administration d'agonistes de la GnRH (Gonadotrophin Releasing Hormone) en phase lutéale des protocoles substitutifs de transferts d'embryons congelés : étude prospective randomisée

Gynecologie Obstetrique et Fertilite

Volumn 43, Issue 11, 2015, Pages 728-734

  Gogce, M ^a   Benchaib, M ^a   Hadj, S ^a   Bordes, A ^a   Du Menildot, P ^a   Lornage, J ^a   Salle, B ^a  

^a HOSPICES CIVILS DE LYON   (France)

Author keywords

Assisted reproduction technology; Frozen thawed embryo transfer cycle; GnRH agonists; Implantation

Indexed keywords

GONADORELIN AGONIST; PROGESTERONE; TRIPTORELIN; GONADORELIN;

ARTICLE; BLASTOCYST; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FREEZE THAWING; HUMAN; LUTEAL PHASE; NIDATION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; ADULT; AGONISTS; CRYOPRESERVATION; HEAT; IN VITRO FERTILIZATION; PHYSIOLOGY; PREGNANCY; PROSPECTIVE STUDY;

ADULT; BLASTOCYST; CRYOPRESERVATION; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HOT TEMPERATURE; HUMANS; LUTEAL PHASE; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; TRIPTORELIN PAMOATE;

EID: 84947496195     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2015.07.005     Document Type: Article

References (47)

1. Norwitz ER, Schust DJ, Fisfer SJ. Implantation and the survival of early pregnancy. N Engl J Med 2001;345:1400-8.
2. Tavaniotou A, Albano C, Smitz J, Devroey P. Impact of ovarian stimulation on corpus luteum function and embryonic implantation. J Reprod Immunol 2002;55:123-30.
3. Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 2002;17:2287-99.
4. Daya S, Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev 2004;3.
5. Oliveira JB, Baruffi R, Petersen CG, Mauri AL, Cavagna M, et al. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reprod Biol Endocrinol 2010;8:107.
6. Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzi TB, Devroey P, et al. Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis. Hum Reprod Update 2011;0: 1-7.
7. Van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2011;10.
8. Ghobara T, Vanderkerchove P. Cycle regimens for frozen-thawed embryo transfer. Cochrane Database syst Rev 2008;1.
9. Glujovsky D, Pesce R, Fiszbajn G, Sueldo C, Hart R, et al. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev 2010;1.
10. Groenewoud ER, Cantineau AE, Kollen BJ, Macklon NS, Cohlen BJ. What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update 2013;19(5):458-70.
11. Givens CR, Markun LC, Ryan IP, Chenette PE, Herbert CM, et al. Outcomes of natural cycles versus programmed cycles for 1677 frozen-thawed embryo transfers. Reprod Biomed Online 2009;19:380-4.
12. Tomás C, Alsbjerg B, Martikainen H, Humaidan P. Pregnancy loss after frozen-embryo transfer-a comparison of three protocols. Fertil Steril 2012;98(5): 1165-9.
13. Morozov V, Ruman J, Kenigsberg D, Moodie G, Brenner S. Natural cycle cryo-thaw transfer may improve pregnancy outcome. J Assist Reprod Genet 2007;24:119-23.
14. Kang IS, Kuehl TJ, Siler-Khodr TM. Effect of treatment with gonadotropin-releasing hormone analogues on pregnancy outcome in the baboon. Fertil Steril 1989;58:846-53.
15. Chardonnens D, Sylvan K, Walker Dilys, Bischof P, Sakkas D, et al. Triptorelin acetate administration in early pregnancy: case reports and review of the literature. Eur J Obstet Gynecol Reprod Biol 1998;80(2):143-9.
16. Balasch J, Martinez F, Jove I, Cabre L, Coroleu B, et al. Inadvertent gonadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Hum Reprod 1993;8:1148-51.
17. Smitz J, Camus M, Devroey P, Bollen N, Tournaye H, et al. The influence of inadvertent intranasal buserelin administration in early pregnancy. Hum Reprod 1991;6(2):290-3.
18. Pirard C, Donnez J, Loumaye E. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin. Hum Reprod 2005;20(7):1798-804.
19. Pirard C, Donnez J, Loumaye E. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Hum Reprod 2006;21(7):1894-900.
20. Tesarik J, Hazout A, Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod 2004;19(5):1176-80.
21. Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod 2006;21(10):2572-9.
22. Qublan H, Amarin Z, Al-Qudah M, Diab F, Nawasreh M, et al. Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of < or = 7 mm on day of egg retrieval. Hum Fertil (Camb) 2008;11:43-7.
23. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, et al. The presence of gonadotropin receptors in no pregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab 1990;70:421-30.
24. Perrier d'Hauterive S, Berndt S, Tsampalas M, Charlet-Renard C, Dubois M, et al. Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation? Gynecol Obstet Invest 2007;64(3):156-60.
25. Licht P, Fluhr H, Neuwinger J, Wallwiener D, Wildt L. Is human chorionic gonadotropin directly involved in the regulation of human implantation? Mol Cell Endocrinol 2007;269(1-2):85-92.
26. Piccini M-P, Guidizi M-G, Biagiotti R, Beloni L, Giannarini L, et al. Progesterone favors the development of human T helper cells producine Th-2 type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995;155:128-33.
27. Tsampalas M, Gridelet V, Berndt S, Foidart JM, Geenen V, et al. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J Reprod Immunol 2010;85(1):93-8.
28. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999;340:1796-7.
29. Nawroth F, Ludwig M. What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in oestrogen/ progesterone replacement protocols? Hum Reprod 2005;20(5):1127-34.
30. Evain-Brion D. The 2 differentiation pathways of the human trophoblast. Gynecol Obstet Fertil 2001;29(7-8):497-502.
31. Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, et al. Uterine contractions at the time of embryo transfer after pregnancy rates after in vitro fertilization. Hum Reprod 1998;13:1968-74.
32. Usadi RS, Groll JM, Lessey BA, Lininger RA, Zaino RJ, et al. Endometrial development and function in experimentally induced luteal phase deficiency. J Clin Endocrinol Metab 2008;93(10):4058-64.
33. Cheng CK, Leung PC. Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 2005;26:283-306.
34. Raga F, Casan EM, Kruessel JS, Wen Y, Huang HY, et al. Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biol Reprod 1998;59:661-9.
35. Casan EM, Raga F, Kruessel JS. Immunoreactive gonadotropin-releasing hormone (GnRH) expression in cycling human endometrium of fertile patients. Fertil Steril 1998;70:102-6.
36. Chou CS, Zhu H, Shalev E, MacCalman CD, Leung PC. The effects of gonadotropin-releasing hormone (GnRH) I and GnRH II on the urokinase-type plasminogen activator/plasminogen activator inhibitor system in human extravillous cytotrophoblasts in vitro. J Clin Endocrinol Metab 2002;87:5594-603.
37. Chou CS, Zhu H, MacCalman CD, Leung PC. Regulatory effects of gonadotropinreleasing hormone (GnRH) I and GnRH II on the levels of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of metallo-proteinases-1 in primary cultures of human extravillous cytotrophoblasts. J Clin Endocrinol Metab 2003;88:4781-90.
38. Liu J, MacCalman CD, Wang YL, Leung PC. Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways. Mol Endocrinol 2009;23:1014-21.
39. Raga F, Casan EM, Kruessel. The role of gonadotrophin releasing hormone (GnRH) in murine preimplantation embryonic development. Endocrinology 1999;140:3705-12.
40. Nam DH, Lee SH, Kim HS, Lee GS, Jeong YW, et al. The role of gonadotropin-releasing hormone (GnRH) and its receptor in development of porcine preimplantation embryos derived from in vitro fertilization. Theriogenology 2005;63:190-201.
41. Kawamura K, Fukuda J, Kumagai J, Shimizu Y, Kodama H, et al. Gonadotropin-releasing hormone I analog acts as an antiapoptotic factor in mouse blastocysts. Endocrinology 2005;146:4105-16.
42. Lin L, Roberts VJ, Yen S. Expression of human gonadotropinreleasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J Clin Endocrinol Metab 1995;80:580-5.
43. Barnea ER, Kaplan M, Naor Z. Comparative stimulatory effect of gonadotropin releasing hormone (GnRH) and GnRH agonist upon pulsatile human chorionic gonadotropin secretion in superfused placental explants: reversible inhibition by a GnRH antagonist. Hum Reprod 1991;6:1063-9.
44. Merz WE, Erlewein C, Licht P, Harbarth P. The secretions of human chorionic gonadotrophin as well as the alpha- and beta-messenger ribonucleic acid levels are stimulated by exogenous gonadoliberin pulses applied to first trimester placenta in a superfusion culture system. J Clin Endocrinol Metab 1991;73:84-92.
45. Iwashita M, Kudo Y, Shinozaki Y, Takeda Y. Gonadotropin releasing hormone increases serum human chorionic gonadotropin in pregnant women. Endocr J 1993;40:539-44.
46. Edgar DH, Gook DA. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update 2012;18(5):536-54.
47. Hesters L, Achour-Frydmana N, Mandelbaumb J, Levy R. Vitrification embryonnaire : état des pratiques en France par les BLEFCO. Gynecol Obstet Fertil 2013;41(9):554-7.